Research Centre | Company Search | Charting | Stock Screener | Performance Tables | Financial Diary | Investing Board
GlaxoSmithKline (GSK)
Share Price: 1,522.80p Change Today: -8.60p  Market Cap: 75,536m

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart (24-09-2018)

1 Day Chart

6 Month Chart

6 Month Chart

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 26,505.00 6,647.00 108.40p 14.9 n/a -3% 78.00p 4.8%
31-Dec-14 23,006.00 2,968.00 95.40p 14.4 n/a -12% 80.00p 5.8%
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-18 30,334.56 7,701.55 111.46p 13.7 n/a -0% 80.01p 5.2%
31-Dec-19 31,155.89 7,796.36 115.77p 13.2 3.4 +4% 80.22p 5.2%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
11-Sep-18 Transfer From Emma Walmsley 0.000p 8 0.00
11-Sep-18 Transfer From Simon Dingemans 0.000p 8 0.00
11-Sep-18 Transfer From David Redfern 0.000p 8 0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Price Data

Currency UK Pounds
Share Price 1,522.80p
Change Today -8.60p
% Change -0.56 %
Volume 4,541,296
24-Sep-18 Close 1,522.80p
Shares Issued 4,960.32m
Market Cap 75,536m
Year End 31-Dec-17

What The Brokers Say

Strong Buy 10
Buy 2
Neutral 12
Sell 0
Strong Sell 2
Total 26
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q2 Q1
Ex-Div 09-Aug-18 10-May-18
Paid 11-Oct-18 12-Jul-18
Amount 19.00p 19.00p

Trades for 24-Sep-2018

Time Volume / Share Price
17:04 1,634 @ 1,522.74p
17:04 1,023 @ 1,528.38p
16:55 2,520 @ 1,520.27p
16:54 1,647 @ 1,532.28p
16:54 754 @ 1,526.76p

GlaxoSmithKline Key Personnel

CFO Simon Dingemans
CEO Emma Walmsley



www.bolsamania.com www.sharecast.com http://www.proshareclubs.co.uk/ www.digitallook.com